ACEMIT

Brand name authorized in: Germany

Active ingredients

The drug ACEMIT contains one active pharmaceutical ingredient (API):

1 Acetazolamide
UNII O3FX965V0I - ACETAZOLAMIDE

Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.

Read about Acetazolamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Acetazolamide
S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 06609274, 06609280, 08473229